Sveriges mest populära poddar
Future of Drug Discovery

Ashwini Ghogare - AI, Automation and Drug Discovery (FODD #14)

26 min11 december 2023

In this episode, we speak with Ashwini Ghogare, Head of Artificial Intelligence and Automation in Drug Discovery at ⁠MilliporeSigma⁠, the Global Science and Technology Group at ⁠Merck⁠.

Host: ⁠Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse.

You will learn:

  • About Ashwini’s journey to her current role.
  • How to bridge the gaps between working groups with different skill sets for optimal computational drug discovery.
  • The interplay between AIDDISON™ and SYNTHIA™ to automate the drug discovery process.
  • The industry's critical requirements for progress in the AI drug discovery space.

Things mentioned:

Additional Materials:

First time hearing about Antiverse?

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a primary focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

For more information, please visit ⁠⁠⁠⁠⁠⁠https://www.antiverse.io⁠

Never miss a future event!

We'll notify you when a new event is scheduled. Fill out ⁠⁠⁠⁠⁠this form⁠⁠⁠⁠⁠ to sign up for marketing communications from Antiverse. We post about upcoming events on LinkedIn and Twitter.

LinkedIn: ⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠

X: ⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

Fler avsnitt av Future of Drug Discovery

Visa alla avsnitt av Future of Drug Discovery

Future of Drug Discovery med Murat Tunaboylu finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.